CAS 23672-07-3
:Levosulpirida
- (-)-5-Aminosulfonyl-N-[(1-Ethyl-2-Pyrrolidinyl)Methyl]-2-Methoxy-Benzamide
- (-)-N-1-[Ethylpyrrolidin-2-Ylmethyl]-2-Methoxy-5-Sulfamoylbenzamide
- (-)-Sulpiride
- (S)-(-)-5-(aminosulfonyl)-N-[(1-ethyl-2-pyrrolinyl)methyl]
- (S)-(-)-5-Aminosulfonyl-N-[(1-Ethyl-2-Pyrrolidinyl)Methyl]-2-Methoxybenzamide
- (S)-(-)-N-((1-Ethyl-2-Pyrrolidinyl)Methyl)-5-Sulfamoyl-O-Anisamide
- (S)-(-)-N-((1-Ethyl-2-Pyrrolidinyl)Methyl)-5-Sulfamoyl-O-Anisamide 5-(Aminosulfonyl)-N-((1-Ethyl-2-Pyrrolidinyl)Methyl)-2-Methoxy-Benzamid ( S-(-)-Benzamid
- (S)-(-)-Sulpiride
- (S)-(-)-Sulpiride, Vetranal
- 5-(Aminosulfonyl)-N-[[(2S)-1-ethyl-2-pyrrolidinyl]methyl]-2-methoxybenzamide
- <span class="text-smallcaps">L</span>-Sulpiride
- Benzamide, 5-(aminosulfonyl)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxy-, (S)-
- Benzamide, 5-(aminosulfonyl)-N-[[(2S)-1-ethyl-2-pyrrolidinyl]methyl]-2-methoxy-
- Lesuride
- Levobren
- Levopraid
- Levopride
- Levosulpride
- N-{[(2S)-1-ethylpyrrolidin-2-yl]methyl}-2-methoxy-5-sulfamoylbenzamide
- Rv-12309
- Rv-12309 S-(-)-N-(1-Ethyl-2-Pyrrolidinomethyl)-2-Methoxy-5-Sulfamoylebenzamide
- S(-)-Sulpiride Dopamine D1 Antagonis
- S-(-)-N-(1-Ethyl-2-Pyrrolidinomethyl)-2-Methoxy-5-Sulfamoylebenzamide
- Sulpid
- l-Sulpiride
- o-Anisamide, N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-sulfamoyl-, (-)-
- s-(-)-sulpiride (S)-5-Aminosulfonyl-N-[(1-ethylpyrrolidin-2-yl)methyl]-2-methoxybenzamide
- LEVOSULPIRIDE/LEVOSULPRIDE
- (s)-(-)-o-anisamid
- LEVOSULPIRIDE
- Benzamide, 5-(aminosulfonyl)-N-[[(2S)-1-ethyl-2-pyrrolidinyl]methyl]-2-methoxy-(9CI)
- Ver más sinónimos
(S)-(-)-Sulpiride
CAS:Fórmula:C15H23N3O4SPureza:>98.0%(T)(HPLC)Forma y color:White to Light yellow powder to crystalPeso molecular:341.43N-{[(2S)-1-ethylpyrrolidin-2-yl]methyl}-2-methoxy-5-sulfamoylbenzamide
CAS:Fórmula:C15H23N3O4SPureza:98%Forma y color:SolidPeso molecular:341.4258Levosulpiride
CAS:Levosulpiride (S-(-)-Sulpiride) is the (S)-enantiomer of sulpiride, which is a D2 receptor antagonist, an atypical antipsychotic drug of the benzamide class.Fórmula:C15H23N3O4SPureza:98.20% - 99.88%Forma y color:White SolidPeso molecular:341.43Levosulpiride
CAS:Fórmula:C15H23N3O4SPureza:98.0 - 102.0 %Forma y color:White to off-white powderPeso molecular:341.43Levopride
CAS:Applications Antipsychotic; antidepressant; antiemetic.
References Karolidis, D., et al.: Med. Chem., 6, 259 (2010), Cummings, D., et al.: J. Pharmacol. Exper. Ther., 335, 518 (2010),Fórmula:C15H23N3O4SForma y color:NeatPeso molecular:341.43S-(-)-Sulpiride
CAS:Producto controladoApplications Dopamine D2 and D3-receptor antagonist. Antipsychotic; antidepressant; antiemetic.
References Pitre, D., et al.: Anal. Profiles Drug Subs., 17, 607 (1988), Wagstaff, A.J., et al.: CNS Drugs, 2, 313 (1994),Fórmula:C15H23N3O4SForma y color:NeatPeso molecular:341.43Levosulpiride - Bio-X ™
CAS:Producto controladoLevosulpiride is a pharmacological agent which binds to dopamine (D2) receptors in the brain and gastrointestinal tract. It is used both to treat conditions that cause abnormal movements for e.g. Parkinson's disease and tardive dyskinesia, and also as an antiemetic and to treat certain gastric disorders. Additional to acting as a dopamine receptor antagonist, Levosulpiride also binds to α1-acid glycoprotein and has been shown to have a concentration-dependent effect on serum prolactin levels, with higher doses leading to increased levels, as well as an effect on basic fibroblasts.
Fórmula:C15H23N3O4SPureza:(%) Min. 95%Forma y color:PowderPeso molecular:341.43 g/molLevosulpiride
CAS:Producto controladoLevosulpiride is a pharmacological agent which binds to dopamine (D2) receptors in the brain and gastrointestinal tract. It is used both to treat conditions that cause abnormal movements for e.g. Parkinson's disease and tardive dyskinesia, and also as an antiemetic and to treat certain gastric disorders. Additional to acting as a dopamine receptor antagonist, Levosulpiride also binds to α1-acid glycoprotein and has been shown to have a concentration-dependent effect on serum prolactin levels, with higher doses leading to increased levels, as well as an effect on basic fibroblasts.Fórmula:C15H23N3O4SPureza:Min. 95%Forma y color:PowderPeso molecular:341.43 g/mol













